Cynthia D. Green, PhD, MBA

Connecticut Innovations, Pfizer, CuraGen

Cyndi Green has been managing director at Connecticut Innovations since joining early 2020. In 2019, Cyndi retired from Pfizer in NYC where she was head of Business Development Search and Evaluation for anti-infectives and vaccines. Her technical leadership at Pfizer led to the formation of Pfizer/GSK spin-out ViiV Healthcare, as well as the acquisitions of an anti-infective franchise from AZ and vaccine portfolios from Baxter and GSK. Prior to Pfizer, she held various scientific and business positions at CuraGen and her expertise spans the spectrum of drug development from preclinical to marketed assets, technologies, diagnostics, and research platforms. Cyndi is on the board of directors of CaroGen, Thetis, CytoVeris, and BioCT, and led investments in Dugri, Oova, and Aztek. In addition to supporting the CI portfolio, Cyndi mentors and provides consultant expertise for a variety of organizations, including ABCT, eLabNYC, Springboard Enterprises, and Endless Frontier Labs. Cyndi has a doctorate in molecular biology from SUNY Buffalo, did her postdoctoral work at Yale University, and received an MBA from Rensselaer Polytechnic Institute.